🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Dilated Cardiomyopathy (DCM)

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a1 site📍 Sioux Falls Sanford Health A Phase 1 AAV Gene Therapy Trial Evaluating Safety and Preliminary Efficacy of RP-A701 in Subjects With BAG3 Dilated Cardiomyopathy NCT07137338Phase 13 sites📍 San Diego📍 Rochester📍 Charleston Rocket Pharmaceuticals Inc. · Tests: RP-A701 is a recombinant viral vector composed of an AAV serotype rh.74 (AAVrh.74) capsid encapsulating the transgene, … AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor NCT06699056n/a8 sites📍 Orange📍 Pasadena📍 Detroit Peerbridge Health, Inc · Tests: 15-minutes of sitting during COR ECG Acquistion Registry of Cell Therapy in Non-Ischemic Dilated Cardiomyopathy NCT02445534n/a1 site📍 Ljubljana University Medical Centre Ljubljana · Tests: Autologous stem cell therapy A Study of AZD4063 in PLN R14del Dilated Cardiomyopathy NCT07241104Phase 14 sites📍 Amsterdam📍 Groningen📍 Rotterdam AstraZeneca · Tests: AZD4063 UIC Multi-Ethnic DCM Registry NCT07145138n/a1 site📍 Chicago University of Illinois Chicago Molecular and Imaging Studies of Cardiovascular Health and Disease NCT02804269n/a1 site📍 Singapore National Heart Centre Singapore · Tests: Cardiovascular Magnetic Resonance, Fatmass measurement Protein A Immunoadsorption in Dilated Cardiomyopathy (RPIA-DCM) NCT06922851NA1 site📍 Wuhan Union Hospital, Tongji Medical College, Huazhong University… · Tests: Immunoadsorption The Application of T1 Mapping in Real-World NCT07354646n/a1 site📍 Beijing Chinese Academy of Medical Sciences, Fuwai Hospital · Tests: Magnetic Resonance Imaging with Contrast Outcome-targeted Therapy: Principle and Outcome Evaluation: Clinical Study and Phenotype-genotype Correlation NCT06632834Phase 21 site📍 Taipei County National Taiwan University Hospital · Tests: simvastatin therapy Study of Personalized Allocation of Defibrillators in Non-ischemic Heart Failure (SPANISH-1) NCT06055504NA31 sites📍 Santiago de Compostela📍 L'Hospitalet de Llobregat📍 Sabadell Consorcio Centro de Investigación Biomédica en Red (CIBER) · Tests: Control Strategy, Personalized precision ICD implantation Strategy based in genetic findings and CMR results Modifying Factors in Striated Muscle Laminopathies NCT05394506NA8 sites📍 Bron📍 Paris📍 Montpellier Institut National de la Santé Et de la Recherche Médicale, … · Tests: Skin Biopsy, Muscle biopsy ALXN2350 in Adult Participants With BAG3-Associated Dilated Cardiomyopathy NCT07218887Phase 1, Phase 211 sites📍 Birmingham📍 Palo Alto📍 Boston Alexion Pharmaceuticals, Inc. · Tests: ALXN2350 Safety and Efficacy of FAP iCDC in End-stage Dilated Cardiomyopathy NCT06902896Phase 1, Phase 21 site📍 Hangzhou Second Affiliated Hospital, Zhejiang University, School of … · Tests: FAP immunosuppressive CAR-DC Safety and Efficacy of Second Infusion of FAP iCDC in End-stage Dilated Cardiomyopathy NCT07516288Phase 11 site📍 Hangzhou Second Affiliated Hospital, Zhejiang University, School of … · Tests: FAP immunosuppressive CAR-DC Image-Based Prediction of Ventricular Tachycardia Events in Non-ischemic Cardiomyopathy NCT06730464n/a4 sites📍 Milan📍 Lispon📍 Barcelona Centro Medico Teknon Dilated Cardiomyopathy Detection Using AI and Screening With Mobile Technology (DCM-DETECT) NCT06688396NA1 site📍 Lancaster Lancaster General Hospital · Tests: Mobile 6L AI-EKG Screening Endocardial Delivery for Myocardial Regeneration Using Allogeneic iPSC-derived Cardiomyocyte Spheroids for HF With Systolic Dysfunction (EMERALD Study) NCT07347197Phase 1, Phase 25 sites📍 Tsukuba📍 Kawasaki📍 Matsumoto Heartseed Inc. · Tests: HS-005 The Effects of Sirolimus in Patients With Dilated Cardiomyopathy Infected With Kaposi Sarcoma-associated Virus NCT06236022Phase 41 site📍 Wuhan Tongji Hospital · Tests: Sirolimus Assessment of the Predictive Value of Anti-beta1AR and Anti-L-CaC Antibodies in the Evolution to Dilated Cardiomyopathy in Patients With Acute Viral Myocarditis NCT06742008n/a1 site📍 Wuhan Union Hospital, Tongji Medical College, Huazhong University… Cardiac Magnetic Resonance for Risk Stratification in Dilated Cardiomyopathy NCT04990297n/a1 site📍 Beijing Chinese Academy of Medical Sciences, Fuwai Hospital Prognostic Values of Coronary Microvascular Dysfunction in Patients With Dilated Cardiomyopathy NCT07293338n/a1 site📍 Hangzhou Second Affiliated Hospital, Zhejiang University, School of … · Tests: coronary angiography Multimodal and Multidisciplinary Approach to Optimize Diagnostic, Prognostic, and Therapeutic Management of Patients with Non-ischemic Cardiomyopathies and Arrhythmogenic-inflammatory Phenotypes: a Multicenter, Observational, Retrospective and Prospective Registry Study. NCT06607471n/a1 site📍 Milan Scientific Institute San Raffaele · Tests: Support treatment, cardiac medical treatment, aetiology-specific treatment, device implant, arrhythmia ablation, Suppor… Bromocriptine in Dilated Cardiomyopathy Among Women of Reproductive Age NCT06250257Phase 31 site📍 Jimma Jimma University · Tests: Bromocriptine mesylate plus standard GDMT A 10-Minute Cardiovascular Magnetic Resonance Protocol for Cardiac Disease NCT04464655n/a1 site📍 Montreal McGill University Health Centre/Research Institute of the M… Multimodal Analysis of Endomyocardial Biopsies NCT07359690n/a1 site📍 Essen University Hospital, Essen Early Treatment With Candesartan vs Placebo in Genetic Carriers of Dilated Cardiomyopathy (EARLY-GENE Trial) NCT05321875Phase 31 site📍 Majadahonda Cristina Avendaño Solá · Tests: Candesartan Characterization of Patients With Cardiomyopathy to Identify Critical Patients Candidates for Cardiac Transplantation NCT06813443n/a3 sites📍 Bologna📍 Roma📍 Florence IRCCS Azienda Ospedaliero-Universitaria di Bologna Mayo AVC Registry and Biobank NCT03049254n/a2 sites📍 Rochester📍 Papworth Everard Mayo Clinic DZHK TORCH-Plus is a Registry for Patients With Cardiomyopathies and Serves as Source for Cardiovascular Research Studies NCT04265040n/a1 site📍 Heidelberg University Hospital Heidelberg
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy